Survival trends among patients with metastatic non-small cell lung cancer before and after the approval of immunotherapy in the United States: A Surveillance, Epidemiology, and End Results database-based study.
Yating WangKyle KondratJanak AdhikariQuynh NguyenQian YuDipesh UpretyPublished in: Cancer (2024)
In summary, the survival rate of patients with metastatic NSCLC has improved since the introduction of immunotherapy.